Trial Number
287-22
Condition
Cystic Fibrosis
Participant Age Range
18 years and older
Participant Gender
Any
Enrolling Participants
Yes
Overview
“A Phase 1 Open-Label, Multicenter Study to Assess the Safety and Efficacy of ANG003 in Patients with Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis”
Phase 1 Study to Assess Safety and Efficacy of ANG003.